Literature DB >> 32892415

Signs of early cellular dysfunction in multiple system atrophy.

M Herrera-Vaquero1, A Heras-Garvin1, F Krismer1, R Deleanu2, S Boesch1, G K Wenning1, N Stefanova1.   

Abstract

AIMS: Multiple system atrophy (MSA) is a fatal neurodegenerative disease that belongs to the family of α-synucleinopathies. At post mortem examination, intracellular inclusions of misfolded α-synuclein are found in neurons and oligodendrocytes and are considered to play a significant role in the pathogenesis. However, the early steps of the disease process are unknown and difficult to study in tissue derived from end-stage disease.
METHODS: Induced pluripotent stem cells (iPSCs) were generated from patients' and control skin fibroblasts and differentiated into NCAM-positive neural progenitor cells (NPCs). The mitochondrial morphology and function were assessed by immunocytochemistry and high resolution respirometry. The ability to cope with exogenous oxidative stress was tested by exposure to different doses of luperox. The expression of α-synuclein was studied by immunocytochemistry.
RESULTS: We identified increased tubulation of mitochondria with preserved respiration profile in MSA-derived NPCs. Exposure of these cells to exogenous oxidative stress even at low doses, triggered an excessive generation of reactive oxygen species (ROS) and cleavage of caspase-3. MSA-derived NPCs did not present changed levels of SNCA gene expression nor intracellular aggregates of α-synuclein. However, we identified disease-related translocation of α-synuclein to the nucleus.
CONCLUSIONS: Our results show early cellular dysfunction in MSA-derived NPCs. We identified changes in the redox homeostasis which are functionally compensated at baseline but cause increased susceptibility to exogenous oxidative stress. In addition, nuclear translocation of α-synuclein in MSA-derived NPCs supports an early cellular stress response which may precede the neurodegenerative process in this disorder.
© 2020 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society.

Entities:  

Keywords:  high resolution respirometry; induced pluripotent stem cells; mitochondria; multiple system atrophy; oxidative stress; α-synuclein

Year:  2020        PMID: 32892415      PMCID: PMC7891639          DOI: 10.1111/nan.12661

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  59 in total

1.  Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.

Authors:  J Li; Q Huang; X Long; X Guo; X Sun; X Jin; Z Li; T Ren; P Yuan; X Huang; H Zhang; J Xing
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

Review 2.  The neuropathology of multiple system atrophy and its therapeutic implications.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Auton Neurosci       Date:  2017-11-10       Impact factor: 3.145

3.  Mitochondrial respiratory chain function in multiple system atrophy.

Authors:  M Gu; M T Gash; J M Cooper; G K Wenning; S E Daniel; N P Quinn; C D Marsden; A H Schapira
Journal:  Mov Disord       Date:  1997-05       Impact factor: 10.338

4.  Mutation scanning of the COQ2 gene in ethnic Chinese patients with multiple-system atrophy.

Authors:  Yong Ping Chen; Bi Zhao; Bei Cao; Wei Song; XiaoYan Guo; Qian-Qian Wei; Yuan Yang; Li Xing Yuan; Hui-Fang Shang
Journal:  Neurobiol Aging       Date:  2014-09-18       Impact factor: 4.673

5.  Glial cell death induced by overexpression of alpha-synuclein.

Authors:  N Stefanova; L Klimaschewski; W Poewe; G K Wenning; M Reindl
Journal:  J Neurosci Res       Date:  2001-09-01       Impact factor: 4.164

6.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

7.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

8.  p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy.

Authors:  Yun Ju C Song; Ditte M S Lundvig; Yue Huang; Wei Ping Gai; Peter C Blumbergs; Peter Højrup; Daniel Otzen; Glenda M Halliday; Poul H Jensen
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

9.  Mitochondrial dysfunction and altered ribostasis in hippocampal neurons with cytoplasmic inclusions of multiple system atrophy.

Authors:  Norihisa Maeda; Hiroyuki Honda; Satoshi O Suzuki; Naoki Fujii; Jun-Ichi Kira; Toru Iwaki
Journal:  Neuropathology       Date:  2018-07-01       Impact factor: 1.906

Review 10.  Redox Homeostasis and Mitochondrial Dynamics.

Authors:  Peter H G M Willems; Rodrigue Rossignol; Cindy E J Dieteren; Michael P Murphy; Werner J H Koopman
Journal:  Cell Metab       Date:  2015-07-09       Impact factor: 27.287

View more
  7 in total

1.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

Review 2.  A Mouse Model of Multiple System Atrophy: Bench to Bedside.

Authors:  Nadia Stefanova
Journal:  Neurotherapeutics       Date:  2022-08-22       Impact factor: 6.088

3.  Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.

Authors:  David J Koss; Daniel Erskine; Andrew Porter; Pawel Palmoski; Hariharan Menon; Olivia G J Todd; Marta Leite; Johannes Attems; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2022-07-06       Impact factor: 7.578

Review 4.  Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?

Authors:  Victoria Sidoroff; Pam Bower; Nadia Stefanova; Alessandra Fanciulli; Iva Stankovic; Werner Poewe; Klaus Seppi; Gregor K Wenning; Florian Krismer
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping.

Authors:  Alain Ndayisaba; Ariana T Pitaro; Andrew S Willett; Kristie A Jones; Claudio Melo de Gusmao; Abby L Olsen; Jisoo Kim; Eero Rissanen; Jared K Woods; Sharan R Srinivasan; Anna Nagy; Amanda Nagy; Merlyne Mesidor; Steven Cicero; Viharkumar Patel; Derek H Oakley; Idil Tuncali; Katherine Taglieri-Noble; Emily C Clark; Jordan Paulson; Richard C Krolewski; Gary P Ho; Albert Y Hung; Anne-Marie Wills; Michael T Hayes; Jason P Macmore; Luigi Warren; Pamela G Bower; Carol B Langer; Lawrence R Kellerman; Christopher W Humphreys; Bonnie I Glanz; Elodi J Dielubanza; Matthew P Frosch; Roy L Freeman; Christopher H Gibbons; Nadia Stefanova; Tanuja Chitnis; Howard L Weiner; Clemens R Scherzer; Sonja W Scholz; Dana Vuzman; Laura M Cox; Gregor Wenning; Jeremy D Schmahmann; Peter Novak; Geoffrey S Young; Mel B Feany; Tarun Singhal; Vikram Khurana
Journal:  Cerebellum       Date:  2022-10-03       Impact factor: 3.648

6.  Signs of early cellular dysfunction in multiple system atrophy.

Authors:  M Herrera-Vaquero; A Heras-Garvin; F Krismer; R Deleanu; S Boesch; G K Wenning; N Stefanova
Journal:  Neuropathol Appl Neurobiol       Date:  2020-09-17       Impact factor: 8.090

Review 7.  Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy.

Authors:  Nicole Campese; Alessandra Fanciulli; Nadia Stefanova; Johannes Haybaeck; Stefan Kiechl; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2021-07-28       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.